Innovative Therapies | Transforming Lives

News Archives

Biotech Industry News Archives

02/16/2016 – Work on Broad-Spectrum Drug to Treat Viruses Like Zika, Hepatitis C Speeds Up, Hepatitis News Today

02/06/2016 – As Zika rages, Seattle scientists step up antiviral drug research, Seattle Times

02/02/2016 – Local research could cure Zika virus and the common cold, KOMO News


12/16/2015 – Compound found to trigger innate immunity against viruses, NewsBeat UW Health Sciences

11/9/2015 – Snail venom discovery at Utah school could lead to safer painkillers, The Salt Lake Tribune

10/2/2015 – Kineta develops new pain med for soldiers, Puget Sound Business Journal

9/30/2015 – Seattle scientists developing non-addictive pain drug, KOMO News

9/28/2015 – Kineta Wins $1.1M U.S. Army Contract Toward Non-Opioid Pain Drug Development, GEN News

7/30/2015 – Kineta wins $4M award to develop therapies against viral diseases like Ebola, influenza, others, GeekWire

7/30/2015 – Seattle biotech Kineta lands $4M contract to develop immunotherapy for infectious disease, Puget Sound Business Journal

5/22/2015 – Kineta and partners raising funds to ‘break out of the old biotech model’, GeekWire

5/12/2015 – New drug shows promise against autoimmune diseases, KOMO 4 News

5/5/2015 – Seattle’s Kineta announces promising results for new autoimmune drug, King 5 News

5/5/2015 – Novel Drug From Nature Shows Early Promise, Wall Street Journal

4/21/2015 – Seattle biotech teams with UW to ramp up drug discoveries, Puget Sound Business Journal

4/21/2015 – Kineta, University of Groningen Present New, Positive Data for Dalazatide in ANCA Vasculitis, an Orphan Disease, Business Wire

4/21/2015 – Wave of the future: The Ebola crisis as a tipping point for pharmaceutical R&D, BioPharma Dive

4/20/2015 – Scientists Target New Painkillers From Spider Venom, Wall Street Journal

4/9/2015 – Kineta’s Adjuvants Boost Flu Vaccine Effectiveness in Data Presented at World Vaccine Congress, Business Wire

3/26/2015 – Kineta’s Novel Antiviral Compounds Inhibit Broad Array of Emerging and Current Viruses Including Ebola, Business Wire

2/9/2015 – A new approach to vaccines, King 5 News

1/20/2015 – Kineta CEO on partnership with Seattle Children’s to speed up pediatric drug treatments, Puget Sound Business Journal


1/15/2014 – Seattle biotech Kineta raises $1.3M for psoriasis, anti-viral, pain products, Puget Sound Business Journal

12/12/2014 – Ebola a wakeup call to disease threats, Puget Sound Business Journal

11/18/2014 – Partnering for Cures – Seattle Children’s Research Institute and Kineta, Inc.: Alliance for Children’s Therapeutics

11/07/2014 – Kineta wants to change biotech investing from ‘a black box’ to shorter, transparent model, Puget Sound Business Journal

11/2014 – Innovative Medicine: Researchers develop advanced treatments through Cutting-Edge Science, Alaska Airlines Magazine

10/27/2014 – Mining Venoms, Chemical & Engineering News

10/21/2014 – Kineta’s plans: Research for Ebola, new funding for psoriasis clinical trials, Puget Sound Business Journal

8/02/2014 – WATCH: Seattle researchers hunting for Ebola cure, Fox News

8/02/2014 – VIDEO: Why is there no Ebola vaccine?, KIRO News

8/02/2014 – Seattle scientists seek an Ebola cure, The Seattle Times

7/11/2014 – Life Sciences: Who’s investing in biomedical firms? Doctors, Puget Sound Business Journal

6/12/2014 – Kineta, Seattle Children’s Research Institute collaborate to develop medications for autoimmune diseases, Pharmaceutical Business Review

6/6/2014 – Collaborative KPI Therapeutics launches to beef up Kineta’s pipeline, FierceBiotech

4/28/2014 – Baylor College of Medicine Releases Asthma Study using Kineta’s ShK-186

3/13/2014 – angelMD Physician Network Invests in Kineta, Inc.

2/25/2014 – Kineta Wins Seattle Business Magazine’s Top “Achievement in Biopharmaceuticals” Award at Annual Health Care Leaders Salute

2/4/2014 – Novel Drugs Challenge Anti-TNFs for RA Treatment, Genetic Engineering & Biotechnology News


12/5/2013 – Kineta: Creative Financing Bridges the “Valley of Death”, PharmaExec

11/4/2013 – Partnering For Cures Presentation – Kineta, Inc

11/4/2013 – Kineta teams up with UW researchers on $6.8M project to improve vaccines, Puget Sound Business Journal

10/31/2013 – A new model for drug development, Seattle Business

8/9/2013 – Streamlining Biotech Angel Returns, Private Wealth

7/30/2013 – Sea Creatures’ Venom Could be Used to Treat Obesity, Pain, More, Komo News

7/12/2013 – Treatments from Toxins: New Drugs May Come from Some Dangerous Places, Time

7/12/2013 – Life Sciences: Biotechs finding ways to speed up payday, Puget Sound Business Journal

5/30/2013 – Autoimmune Drug Candidate Helps Mice Keep Trim Waists, BioWorld Today

5/22/2013 – VC: Kineta, Oligomerix gain fresh venture backing for R&D programs, FierceBiotech

5/21/2013 – Kineta, Scouring the World for Cash, Finds Oil Money, Xconomy

4/30/2013 – Seattle Biotech Kineta has a Plan for Faster Investor Returns, Puget Sound Business Journal

3/19/2013 – From Toxins to Therapeutics, TheScientist

2/7/2013 – RLB Holdings backs drug developer Kineta, AltAssets

2/5/2013 – Former oil trader, Yankees part-owner invests in Kineta, GeekWire

1/25/2013 – Two Kineta Drug Programs Featured in National Geographic Magazine


8/21/2012 – Kineta uses unorthodox strategy to push autoimmune drug into clinic, FierceBiotech


8/2011 – Seattle biotech gets NIH grant to combat rare viruses, Puget Sound Business Journal

3/2011 – VCs Not Welcome, Puget Sound Business Journal


7/2010 – Tax Credit from Feds on the Way, Puget Sound Business Journal

6/2010 – Seattle Biotech Wins Over Heartfelt Funding, Seattle Times


11/10/2009 – Kineta Rakes in Half of $13 Million Federal Contract, Xconomy

11/1/2009 – Start Up Profiles Kineta Business Model

8/1/2009 – Pharmaceutical Executive Profiles Kineta in “Hot Biotech” Issue

7/8/2009 – Kineta Acquires Multiple Sclerosis, Diabetes Drug Candidate, Xconomy

1/2009 – Seattle biotech Kineta funds research step by step, Seattle Times